Generated by GPT-5-mini| Breast Cancer Research Foundation | |
|---|---|
| Name | Breast Cancer Research Foundation |
| Formation | 1993 |
| Founder | Evelyn Lauder |
| Type | Nonprofit |
| Headquarters | New York City |
| Region served | United States, International |
| Focus | Breast cancer research funding |
Breast Cancer Research Foundation is a nonprofit organization dedicated to funding clinical and translational research for breast cancer. Established in 1993 by Evelyn Lauder and supported by fundraising models linked to Estée Lauder Companies, the foundation has become a major funder within the ecosystem of medical research and oncology. It awards grants to investigators at institutions such as Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, Johns Hopkins Hospital, and global partners including Royal Marsden Hospital and Institut Curie.
The organization was founded in 1993 by Evelyn Lauder after collaborations with advocates associated with Susan G. Komen for the Cure and philanthropic efforts connected to Estée Lauder Companies. Early years saw partnerships and visibility through campaigns similar to those run by American Cancer Society and fundraising events modeled on initiatives from Susan G. Komen. Expansion occurred during the 2000s alongside collaborations with academic centers like Columbia University Irving Medical Center, Harvard Medical School, and University of California, San Francisco as well as international ties to Cancer Research UK and the European Institute of Oncology.
The foundation's mission emphasizes accelerating actionable science through investments in basic, translational, and clinical projects at institutions such as Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, MD Anderson Cancer Center, and Mount Sinai Health System. Funding priorities include targeted therapies tied to discoveries at Broad Institute, biomarker development in programs connected with Fred Hutchinson Cancer Research Center, and immunotherapy approaches informed by work at National Cancer Institute and University of Pennsylvania. Emphasis on survivorship research links to programs at Moffitt Cancer Center, disparities research aligns with community initiatives in partnership with Centers for Disease Control and Prevention, and global capacity building leverages networks like WHO collaborations.
Major initiatives have included investment tracks for precision medicine projects aligned with efforts at Broad Institute, tumor microenvironment studies similar to those at Cold Spring Harbor Laboratory, and clinical trial support akin to consortia coordinated through SWOG Cancer Research Network. Programs support early-career investigators comparable to funding models at Howard Hughes Medical Institute and postdoctoral fellowships paralleling awards from Gordon and Betty Moore Foundation. International research networks draw on institutional collaborations with Institut Gustave Roussy, Peter MacCallum Cancer Centre, and Seoul National University Hospital while data-sharing initiatives mirror platforms developed by The Cancer Genome Atlas and International Cancer Genome Consortium.
Grant mechanisms include investigator-initiated grants, program grants, and named awards that echo formats used by Wellcome Trust and V Foundation for Cancer Research. The foundation has created named fellowships honoring donors and advocates, following practices seen at Rockefeller Foundation and Bill & Melinda Gates Foundation. Partnerships span corporate collaborations with Estée Lauder Companies, research partnerships with Merck, Pfizer, and Roche for translational pipelines, and consortia with academic networks including Yale School of Medicine and Stanford Medicine. Collaborative awards also coordinate with government entities like National Institutes of Health and philanthropic coalitions such as United Way in targeted campaigns.
Governance comprises a board of directors with leaders drawn from sectors exemplified by executives from Estée Lauder Companies, clinicians from Memorial Sloan Kettering Cancer Center, and researchers affiliated with Columbia University Irving Medical Center and Harvard Medical School. Executive leadership roles have been held by figures with experience in nonprofit management similar to leaders at American Red Cross and Susan G. Komen for the Cure, and scientific advisory committees include investigators from Dana-Farber Cancer Institute, Fred Hutchinson Cancer Research Center, and the National Cancer Institute. Financial oversight and audit practices reflect standards used by large nonprofits such as Bill & Melinda Gates Foundation and regulatory interactions with agencies like Internal Revenue Service.
Fundraising channels include signature campaigns tied to Estée Lauder Companies product promotions, benefit events similar to galas hosted by Metropolitan Museum of Art, and digital campaigns leveraging platforms used by organizations such as UNICEF and American Cancer Society. Public engagement strategies encompass awareness efforts during observances like Breast Cancer Awareness Month coordinated with media partners including outlets comparable to The New York Times and Vogue, survivor storytelling collaborations reminiscent of initiatives by Susan G. Komen for the Cure, and educational outreach through partnerships with academic medical centers like Mount Sinai Health System and Johns Hopkins Hospital.
Category:Medical research foundations Category:Cancer charities Category:Organizations established in 1993